You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】騰訊未跌至減持價 資金即市好淡分歧 騰訊購18314 沽20153 牛61848 熊59309/ 全場貼恆指牛61965 熊64698
阿思達克 04-08 10:54
美股隔晚變動幅度不大,道指收報33446點,升16點(或0.05%)。恆指昨升抵29100點後持續向下,收報28674點,跌263點(或0.9%)。今早先跌後回升,再上試兩萬九關口。恆指好倉(牛證及認購權證)昨淨流入逾1.4億港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出逾8400萬元,反映投資者看好港股將見反彈。昨日恆指牛證街貨重貨區為收回價28100至28199點,而熊證街貨重貨區為收回價29500至29599點。

騰訊(00700)大股東Prosus據報以每股595元減持約1.9億股騰訊股份,涉資超過1140億元,但承諾未來三年不再沽售騰訊股票。騰訊上日低收3.8%於629.5元,已率先跑輸大型科企,今早曾再跌逾2%,低見614元,其後跌勢收窄,重返620元附近。昨有逾1億元淨流入其好倉,淡倉同日則有逾1400萬元淨流出。

據報淘寶特價版外,阿里巴巴(09988)旗下閒置物品交易平台「閒魚」亦向微信提交小程序申請。另「股神」巴菲特的拍檔芒格上季斥近3億元建倉阿里巴巴美股。不過,阿里巴巴昨以近全日低位222元收市,下跌1.6%。今早低開後逐步回升,重上225元。上日分別有約720萬元和逾630萬元淨流入其好倉和淡倉。

德勤發表報告指,首季本港新股上市融資總額錄1328億元,按年增長8.4倍,全球排行第二。不過市場繼續消化內地擬新設證券交易所吸引中資企業回流的消息,港交所(00388)昨收跌2.4%於457.4元,今早先跌後回升1%,曾重返464元之上的水平。上日有逾2100萬元淨流入其好倉,淡倉同日則有逾200萬元淨流出。

藥明生物(02269)的無錫生產基地已順利完成美國食品藥品監督管理局的GMP檢查,股份上日逆市收升1.43%,報106.6元,盤中曾升至108.3元的一個月高位。今早回落近3%,曾失守103元。昨有約30萬元淨流入其好倉,淡倉同日亦有逾90萬元淨流入。

快手(01024)昨曾挫近5%至270元邊,收市仍跌3.6%,報274.8元,結束兩日反彈走勢。今早曾跌逾2%,低見268元,其後跌幅收窄,於270元關徘徊。昨有逾830萬元淨流入其好倉,淡倉同日則有小量資金淨流出。

瑞通相關認股證之選擇:

騰訊輕微價外、中短期購18314,行使價:675.5元,2021年7月到期,實際槓桿:7.4倍

騰訊輕微價外、短期沽20153,行使價:566.28元,2021年6月到期,實際槓桿:8.2倍

阿里輕微價外、中短期購29646,行使價:253.888元,2021年7月到期,實際槓桿:8倍

阿里貼價、中短期沽27517,行使價:212.88元,2021年7月到期,實際槓桿:5.8倍

港交輕微價外、中短期購11013,行使價:500.5元,2021年7月到期,實際槓桿:8倍

港交輕微價外、中短期沽18311,行使價:399.8元,2021年10月到期,實際槓桿:6.3倍

藥明價外、中短期購26864,行使價:126.88元,2021年8月到期,實際槓桿:4.3倍

快手價外、中短期購13107,行使價:333元,2021年9月到期,實際槓桿:4.3倍

快手輕微價外、中短期沽22413,行使價:233.88元,2021年10月到期,實際槓桿:2.7倍

瑞通相關牛熊證之選擇:

全場最高收回價的恆指牛證61965,收回價:28577點,槓桿比率:67.9倍

恆指牛證61672,收回價:28060點,槓桿比率:44.3倍

恆指熊證64698,收回價:29340點,槓桿比率:39倍

騰訊牛證61848,收回價:574.8元,槓桿比率:10.6倍

高槓桿騰訊牛證59297,收回價:591元,槓桿比率:16.3倍

騰訊熊證59309,收回價:658.88元,槓桿比率:13.1倍

騰訊熊證59309,收回價:658.88元,槓桿比率:13.1倍

阿里牛證52716,收回價:206.88元,槓桿比率:11倍

阿里熊證50080,收回價:245.88元,槓桿比率:7.8倍

港交牛證59280,收回價:443元,槓桿比率:17.2倍

港交熊證54474,收回價:503.88元,槓桿比率:10.3倍

藥明牛證59271,收回價:88.88元,槓桿比率:5.3倍

藥明熊證56714,收回價:118.8元,槓桿比率:6倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account